Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
As a triple agonist, it targets glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptors
Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes
These effects are typically minor enough that many people wonder whether the medication is working at all
when taken orally, it would normally be broken down by stomach enzymes in your GI tract
US$ 22.99
US$ 25.21
US$ 20.30
US$ 22.33
US$ 23.16
US$ 24.74
US$ 29.91
US$ 22.82
US$ 26.97
US$ 23.41
US$ 25.13
US$ 20.44
